Use this dropdown to select your preferred language.
Alcon helps people see brilliantly. As one of Alcon’s vision care technology sites, Alcon in Grosswallstadt/Germany produces more than one billion high quality contact lenses per year. We are a fully integrated site with R&D, Manufacturing and Eurologistics. About 2,000 employees develop, produce and distribute high quality contact lenses which help people see brilliantly and improve people’s lives. Learn more at www.de.alcon.com.
Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care. Being a truly global company, we work in 60 countries and serve patients in more than 140 countries.
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company operates across Specialty and Primary Care areas and is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
The company operates directly in 20 countries employing more than 2,700 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
Over the years, the Research and Development teams at Angelini Pharma discovered and developed several important molecules, among which trazodone and benzydamine. Currently, the programs of research, development, and innovation focus on Brain Health, particularly Mental Health and Epilepsy.
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company operates across Specialty and Primary Care areas and is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
The company operates directly in 20 countries employing more than 2,700 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
Over the years, the Research and Development teams at Angelini Pharma discovered and developed several important molecules, among which trazodone and benzydamine. Currently, the programs of research, development, and innovation focus on Brain Health, particularly Mental Health and Epilepsy.
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company operates across Specialty and Primary Care areas and is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
The company operates directly in 20 countries employing more than 2,700 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
Over the years, the Research and Development teams at Angelini Pharma discovered and developed several important molecules, among which trazodone and benzydamine. Currently, the programs of research, development, and innovation focus on Brain Health, particularly Mental Health and Epilepsy.
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company operates across Specialty and Primary Care areas and is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
The company operates directly in 20 countries employing more than 2,700 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
Over the years, the Research and Development teams at Angelini Pharma discovered and developed several important molecules, among which trazodone and benzydamine. Currently, the programs of research, development, and innovation focus on Brain Health, particularly Mental Health and Epilepsy.